Ranibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 Study
Status:
Withdrawn
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety, tolerability and efficacy of
Ranibizumab and Tocilizumab alone and in combination in eyes with Diabetic Macular Edema.